Souhaitez-vous accéder aux communiqués récents ?

Resuscitec introduces a novel medical system that increases survival rates in cardiac arrest more than fivefold compared to the current standard of care..

Quercis will elevate the conversation on sickle cell disease (SCD) at the Galien Patient Summit - highlighting its Prix Galien USA “Best Startup” nominat..

Recognition highlights company’s antithrombotic platform and late-stage programs designed to transform care in oncology and inflammation driven diseases